» Articles » PMID: 38183080

Impact of Lipodystrophy on Health-related Quality of Life: the QuaLip Study

Overview
Publisher Biomed Central
Specialty General Medicine
Date 2024 Jan 5
PMID 38183080
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lipodystrophy is a rare disease characterized by loss of adipose tissue. Natural history studies have demonstrated significant burden of disease; however, there is limited data on the impact of lipodystrophy on quality of life (QoL) and psychoemotional well-being. The QuaLip study is a prospective observational real-world study that aims to determine the impact of lipodystrophy on QoL and psychoemotional well-being and explore subjective burden of the disease. Sixty-seven adult patients and eight pediatric patients with lipodystrophy were included. Patients were followed up for 24 months and assessments were repeated every three months. Patients were examined by licensed psychiatrists at baseline, and at year 1 and year 2 visits.

Results: Eighteen (27.69%) of 65 adult patients (two subjects refused psychiatric assessment) were diagnosed with a psychiatric disorder (e.g., depressive episodes, mixed anxiety and depressive disorder, anxiety disorder, adjustment disorder, recurrent depression, panic disorder, generalized anxiety disorder, unspecified mood disorder, nonorganic sleep disorder, post-traumatic stress disorder, depressive episode comorbidity, social phobia and obsessive-compulsive disorder comorbidity). Lipodystrophy disease and QoL questionnaires revealed a significant disease burden over the study period. More than one-third of patients reported depression symptoms on the Beck Depression Inventory and more than one-fourth of the patients reported significant hunger throughout the study period. Physical appearance, fatigue, and pain contributed to the disease burden. QoL scores were lower in patients with psychiatric disease and in those with poor metabolic control. Attention deficit hyperactivity disorder, depressive disorder, sub-threshold depressive symptoms, obsessive-compulsive disorder, appetite problems, and issues with physical appearance were identified in selected pediatric subjects.

Conclusions: Lipodystrophy has a significant impact on QoL and psychoemotional well-being. Psychiatric disorders seem to be underdiagnosed among patients with lipodystrophy.

Citing Articles

Anxiety and Body Image Distress in a Type 1 Diabetes Patient With Insulin-Induced Lipodystrophy.

Tahir M, Raja A Cureus. 2025; 16(12):e75225.

PMID: 39759721 PMC: 11700513. DOI: 10.7759/cureus.75225.


Diagnosis, treatment and management of lipodystrophy: the physician perspective on the patient journey.

Patni N, Chard C, Araujo-Vilar D, Phillips H, Magee D, Akinci B Orphanet J Rare Dis. 2024; 19(1):263.

PMID: 38992753 PMC: 11241872. DOI: 10.1186/s13023-024-03245-3.


A rapid action plan to improve diagnosis and management of lipodystrophy syndromes.

Fourman L, Lima J, Simha V, Cappa M, Alyaarubi S, Montenegro Jr R Front Endocrinol (Lausanne). 2024; 15:1383318.

PMID: 38952397 PMC: 11215967. DOI: 10.3389/fendo.2024.1383318.

References
1.
Hawthorne G, Osborne R, Taylor A, Sansoni J . The SF36 Version 2: critical analyses of population weights, scoring algorithms and population norms. Qual Life Res. 2007; 16(4):661-73. DOI: 10.1007/s11136-006-9154-4. View

2.
Smucker M, Craighead W, Craighead L, Green B . Normative and reliability data for the Children's Depression Inventory. J Abnorm Child Psychol. 1986; 14(1):25-39. DOI: 10.1007/BF00917219. View

3.
Hussain I, Garg A . Lipodystrophy Syndromes. Endocrinol Metab Clin North Am. 2016; 45(4):783-797. PMC: 7590232. DOI: 10.1016/j.ecl.2016.06.012. View

4.
Harris D, Carr A . The Derriford Appearance Scale (DAS59): a new psychometric scale for the evaluation of patients with disfigurements and aesthetic problems of appearance. Br J Plast Surg. 2001; 54(3):216-22. DOI: 10.1054/bjps.2001.3559. View

5.
Farooqi I, ORahilly S . Leptin: a pivotal regulator of human energy homeostasis. Am J Clin Nutr. 2009; 89(3):980S-984S. DOI: 10.3945/ajcn.2008.26788C. View